CLAG-M or FLAG-Ida Chemotherapy
CLAG-M or FLAG-Ida Chemotherapy Followed Immediately by Related/Unrelated Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1 Study
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 120 patients (estimated)
- Sponsors
- Fred Hutchinson / University of Washington Cancer Consortium
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, White Blood Cell Stimulant, Radiation Therapy
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1563
- NCT Identifier
- NCT04375631
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.